Molecular mechanisms of tumor resistance to radiotherapy
Y Wu, Y Song, R Wang, T Wang - Molecular Cancer, 2023 - Springer
Background Cancer is the most prevalent cause of death globally, and radiotherapy is
considered the standard of care for most solid tumors, including lung, breast, esophageal …
considered the standard of care for most solid tumors, including lung, breast, esophageal …
[HTML][HTML] Nanotechnology advances in the detection and treatment of cancer: an overview
Over the last few years, progress has been made across the nanomedicine landscape, in
particular, the invention of contemporary nanostructures for cancer diagnosis and …
particular, the invention of contemporary nanostructures for cancer diagnosis and …
Biomimetic metallic nanostructures for biomedical applications, catalysis, and beyond
MT Yaraki, S Zahed Nasab, I Zare… - Industrial & …, 2022 - ACS Publications
Nature has inspired scientists to develop green and sustainable nanomaterials with
biomimetic functions. Particularly, biomimetic metallic nanostructures (biometal NPs) with …
biomimetic functions. Particularly, biomimetic metallic nanostructures (biometal NPs) with …
Cancer stem cells—key players in tumor relapse
M Marzagalli, F Fontana, M Raimondi, P Limonta - Cancers, 2021 - mdpi.com
Simple Summary Cancer is one of the hardest pathologies to fight, being one of the main
causes of death worldwide despite the constant development of novel therapeutic strategies …
causes of death worldwide despite the constant development of novel therapeutic strategies …
Signaling pathways governing breast cancer stem cells behavior
K Song, M Farzaneh - Stem Cell Research & Therapy, 2021 - Springer
Breast cancer is the second common cancer and the leading cause of malignancy among
females overall. Breast cancer stem cells (BCSCs) are a small population of breast cancer …
females overall. Breast cancer stem cells (BCSCs) are a small population of breast cancer …
Dissecting tumor growth: the role of cancer stem cells in drug resistance and recurrence
B Aramini, V Masciale, G Grisendi, F Bertolini, M Maur… - Cancers, 2022 - mdpi.com
Simple Summary Cancer is one of the most debated problems all over the world. Cancer
stem cells are considered responsible of tumor initiation, metastasis, drug resistance, and …
stem cells are considered responsible of tumor initiation, metastasis, drug resistance, and …
Radiation resistance: a matter of transcription factors
C Galeaz, C Totis, A Bisio - Frontiers in oncology, 2021 - frontiersin.org
Currently, radiation therapy is one of the standard therapies for cancer treatment. Since the
first applications, the field of radiotherapy has constantly improved, both in imaging …
first applications, the field of radiotherapy has constantly improved, both in imaging …
Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives
LA Bravo-Vázquez, A Méndez-García… - … in Bioengineering and …, 2023 - frontiersin.org
MicroRNAs (miRNAs) are short (18–25 nt), non-coding, widely conserved RNA molecules
responsible for regulating gene expression via sequence-specific post-transcriptional …
responsible for regulating gene expression via sequence-specific post-transcriptional …
Writers, readers, and erasers RNA modifications and drug resistance in cancer
D Chen, X Gu, Y Nurzat, L Xu, X Li, L Wu, H Jiao… - Molecular Cancer, 2024 - Springer
Drug resistance in cancer cells significantly diminishes treatment efficacy, leading to
recurrence and metastasis. A critical factor contributing to this resistance is the epigenetic …
recurrence and metastasis. A critical factor contributing to this resistance is the epigenetic …
[HTML][HTML] Integrative analysis identified CD38 as a key node that correlates highly with immunophenotype, chemoradiotherapy resistance, and prognosis of head and …
Z He, C Yue, X Chen, X Li, L Zhang, S Tan, X Yi… - Journal of …, 2023 - ncbi.nlm.nih.gov
Head and neck cancer (HNC) is mainly treated by surgery, radiotherapy, and adjuvant
chemotherapy; however, the prognosis of some patients with HNC is poor because of …
chemotherapy; however, the prognosis of some patients with HNC is poor because of …